106 related articles for article (PubMed ID: 32938954)
41. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.
Tse C; Shoemaker AR; Adickes J; Anderson MG; Chen J; Jin S; Johnson EF; Marsh KC; Mitten MJ; Nimmer P; Roberts L; Tahir SK; Xiao Y; Yang X; Zhang H; Fesik S; Rosenberg SH; Elmore SW
Cancer Res; 2008 May; 68(9):3421-8. PubMed ID: 18451170
[TBL] [Abstract][Full Text] [Related]
42. Salinomycin efficiency assessment in non-tumor (HB4a) and tumor (MCF-7) human breast cells.
Niwa AM; D Epiro GF; Marques LA; Semprebon SC; Sartori D; Ribeiro LR; Mantovani MS
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):557-71. PubMed ID: 26932586
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of Bcl-x(L) promotes chemotherapy resistance of mammary tumors in a syngeneic mouse model.
Liu R; Page C; Beidler DR; Wicha MS; Núñez G
Am J Pathol; 1999 Dec; 155(6):1861-7. PubMed ID: 10595916
[TBL] [Abstract][Full Text] [Related]
44. Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal
Prukova D; Andera L; Nahacka Z; Karolova J; Svaton M; Klanova M; Havranek O; Soukup J; Svobodova K; Zemanova Z; Tuskova D; Pokorna E; Helman K; Forsterova K; Pacheco-Blanco M; Vockova P; Berkova A; Fronkova E; Trneny M; Klener P
Clin Cancer Res; 2019 Jul; 25(14):4455-4465. PubMed ID: 31004002
[TBL] [Abstract][Full Text] [Related]
45. Indole-3-Carbinol (I3C) enhances the sensitivity of murine breast adenocarcinoma cells to doxorubicin (DOX) through inhibition of NF-κβ, blocking angiogenesis and regulation of mitochondrial apoptotic pathway.
Hajra S; Patra AR; Basu A; Saha P; Bhattacharya S
Chem Biol Interact; 2018 Jun; 290():19-36. PubMed ID: 29775573
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of toxicity of cypenhymustine, a new anticancer compound, in mice.
Sadhu U; Ghosh M; Bhattacharya S; Dutta S; Das H; Sanyal U
Cancer Lett; 1994 Sep; 85(1):65-72. PubMed ID: 7923104
[TBL] [Abstract][Full Text] [Related]
47. The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma.
Miknyoczki SJ; Chang H; Klein-Szanto A; Dionne CA; Ruggeri BA
Clin Cancer Res; 1999 Aug; 5(8):2205-12. PubMed ID: 10473107
[TBL] [Abstract][Full Text] [Related]
48. EO9: a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models.
Hendriks HR; Pizao PE; Berger DP; Kooistra KL; Bibby MC; Boven E; Dreef-van der Meulen HC; Henrar RE; Fiebig HH; Double JA
Eur J Cancer; 1993; 29A(6):897-906. PubMed ID: 8484984
[TBL] [Abstract][Full Text] [Related]
49. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on a spectrum of mouse and rat tumors.
Mihich E; Gelzer J
Cancer Res; 1968 Mar; 28(3):553-8. PubMed ID: 4966648
[No Abstract] [Full Text] [Related]
50. Differential proteomic profiling identifies novel molecular targets of paclitaxel and phytoagent deoxyelephantopin against mammary adenocarcinoma cells.
Lee WL; Wen TN; Shiau JY; Shyur LF
J Proteome Res; 2010 Jan; 9(1):237-53. PubMed ID: 19894775
[TBL] [Abstract][Full Text] [Related]
51. Antitumor activity and antioxidant status of the methanol extract of Careya arborea bark against Dalton's lymphoma ascites-induced ascitic and solid tumor in mice.
Natesan S; Badami S; Dongre SH; Godavarthi A
J Pharmacol Sci; 2007 Jan; 103(1):12-23. PubMed ID: 17251685
[TBL] [Abstract][Full Text] [Related]
52. The BET bromodomain inhibitor CPI203 overcomes resistance to ABT-199 (venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma.
Esteve-Arenys A; Valero JG; Chamorro-Jorganes A; Gonzalez D; Rodriguez V; Dlouhy I; Salaverria I; Campo E; Colomer D; Martinez A; Rymkiewicz G; Pérez-Galán P; Lopez-Guillermo A; Roué G
Oncogene; 2018 Apr; 37(14):1830-1844. PubMed ID: 29353886
[TBL] [Abstract][Full Text] [Related]
53. Malvidin Abrogates Oxidative Stress and Inflammatory Mediators to Inhibit Solid and Ascitic Tumor Development in Mice.
Sakthivel KM; Kokilavani K; Kathirvelan C; Brindha D
J Environ Pathol Toxicol Oncol; 2020; 39(3):247-260. PubMed ID: 32865916
[TBL] [Abstract][Full Text] [Related]
54. Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice.
Mangues R; Corral T; Kohl NE; Symmans WF; Lu S; Malumbres M; Gibbs JB; Oliff A; Pellicer A
Cancer Res; 1998 Mar; 58(6):1253-9. PubMed ID: 9515813
[TBL] [Abstract][Full Text] [Related]
55. Human breast adenocarcinoma cytotoxicity and modulation of 7,12-dimethylbenz[a]anthracene-induced mammary carcinoma in Balb/c mice by Acacia catechu (L.f.) Wild heartwood.
Monga J; Chauhan CS; Sharma M
Integr Cancer Ther; 2013 Jul; 12(4):347-62. PubMed ID: 23142797
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of mitoxantrone-loaded albumin microspheres for intratumoral chemotherapy of breast cancer.
Almond BA; Hadba AR; Freeman ST; Cuevas BJ; York AM; Detrisac CJ; Goldberg EP
J Control Release; 2003 Aug; 91(1-2):147-55. PubMed ID: 12932646
[TBL] [Abstract][Full Text] [Related]
57. Partial regression, yet incomplete eradication of mammary tumors in transgenic mice by retrovirally mediated HSVtk transfer 'in vivo'.
Sacco MG; Benedetti S; Duflot-Dancer A; Mesnil M; Bagnasco L; Strina D; Fasolo V; Villa A; Macchi P; Faranda S; Vezzoni P; Finocchiaro G
Gene Ther; 1996 Dec; 3(12):1151-6. PubMed ID: 8986442
[TBL] [Abstract][Full Text] [Related]
58. Activity of batracylin (NSC-320846) against solid tumors of mice.
Mucci-LoRusso P; Polin L; Bissery MC; Valeriote F; Plowman J; Luk GD; Corbett TH
Invest New Drugs; 1989 Nov; 7(4):295-306. PubMed ID: 2557298
[TBL] [Abstract][Full Text] [Related]
59. Targeting BCL2 with venetoclax is a promising therapeutic strategy for "double-proteinexpression" lymphoma with
Uchida A; Isobe Y; Asano J; Uemura Y; Hoshikawa M; Takagi M; Miura I
Haematologica; 2019 Jul; 104(7):1417-1421. PubMed ID: 30523053
[TBL] [Abstract][Full Text] [Related]
60. Antiproliferative activity of monastrol in human adenocarcinoma (MCF-7) and non-tumor (HB4a) breast cells.
Marques LA; Semprebon SC; Niwa AM; D'Epiro GF; Sartori D; de Fátima Â; Ribeiro LR; Mantovani MS
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1279-1288. PubMed ID: 27592117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
